Literature DB >> 25083606

Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome.

Annette Fritscher-Ravens1, Detlef Schuppan2, Mark Ellrichmann3, Stefan Schoch3, Christoph Röcken4, Jochen Brasch5, Johannes Bethge3, Martina Böttner6, Julius Klose3, Peter J Milla7.   

Abstract

BACKGROUND & AIMS: We investigated suspected food intolerances in patients with irritable bowel syndrome (IBS) using confocal laser endomicroscopy (CLE) for real-time visualization of structural/functional changes in the intestinal mucosa after food challenge. Patients with functional changes after food challenge (CLE+) were placed on personalized exclusion diets and followed up for long-term symptom relief.
METHODS: Thirty-six IBS patients with suspected food intolerance and 10 patients with Barrett's esophagus (controls) without IBS symptoms were examined by CLE at University Hospital Schleswig-Holstein (Kiel, Germany). Diluted food antigens were administered directly to the duodenal mucosa through the working channel of the endoscope. Epithelial breaks, intervillous spaces, and the number of intraepithelial lymphocytes (IEL) were measured before and after the food challenge. CLE+ patients were placed on exclusion diets, given symptom score questionnaires, and followed up for 1 year; controls resumed their previous diet.
RESULTS: CLE showed a real-time response to food antigens in 22 of 36 patients; no responses were observed in 14 of 36 patients (CLE-) or any of the controls. Baseline IELs were significantly higher in CLE+ than CLE- subjects (P = .004); numbers increased significantly after food challenge (P = .0008). Within 5 minutes of exposure of CLE+ patients to food antigens, IELs increased, epithelial leaks/gaps formed, and intervillous spaces widened. Epithelial leaks and intervillous spaces also increased significantly in CLE+ vs baseline (both P < .001). The concordance of IELs measured by CLE and conventional histology was 70.6%; they did not correlate (P = .89; r(2) = 0.027). Symptom scores improved more than 50% in CLE+ patients after a 4-week exclusion diet and increased to 74% at 12 months; symptoms continued in CLE- patients.
CONCLUSIONS: Based on CLE analysis of IBS patients with a suspected food intolerance, exposure to candidate food antigens caused immediate breaks, increased intervillous spaces, and increased IELs in the intestinal mucosa. These changes are associated with patient responses to exclusion diets. Registered at clinicaltrials.gov (registration number: NCT01692613).
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FODMAP; Food Allergy; Gluten; Imaging

Mesh:

Year:  2014        PMID: 25083606     DOI: 10.1053/j.gastro.2014.07.046

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  73 in total

Review 1.  Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity.

Authors:  Pasquale Mansueto; Alberto D'Alcamo; Aurelio Seidita; Antonio Carroccio
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

Review 2.  The spectrum of noncoeliac gluten sensitivity.

Authors:  Imran Aziz; Marios Hadjivassiliou; David S Sanders
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-30       Impact factor: 46.802

Review 3.  Microscopic enteritis: Bucharest consensus.

Authors:  Kamran Rostami; David Aldulaimi; Geoffrey Holmes; Matt W Johnson; Marie Robert; Amitabh Srivastava; Jean-François Fléjou; David S Sanders; Umberto Volta; Mohammad H Derakhshan; James J Going; Gabriel Becheanu; Carlo Catassi; Mihai Danciu; Luke Materacki; Kamran Ghafarzadegan; Sauid Ishaq; Mohammad Rostami-Nejad; A Salvador Peña; Gabrio Bassotti; Michael N Marsh; Vincenzo Villanacci
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

Review 4.  Nonceliac Wheat Sensitivity: An Immune-Mediated Condition with Systemic Manifestations.

Authors:  Umberto Volta; Roberto De Giorgio; Giacomo Caio; Melanie Uhde; Roberto Manfredini; Armin Alaedini
Journal:  Gastroenterol Clin North Am       Date:  2018-12-13       Impact factor: 3.806

5.  Beyond the H&E: Advanced Technologies for in situ Tissue Biomarker Imaging.

Authors:  Lauren E Himmel; Troy A Hackett; Jessica L Moore; Wilson R Adams; Giju Thomas; Tatiana Novitskaya; Richard M Caprioli; Andries Zijlstra; Anita Mahadevan-Jansen; Kelli L Boyd
Journal:  ILAR J       Date:  2018-12-01

6.  Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study.

Authors:  Chloé Melchior; Moutaz Aziz; Typhaine Aubry; Guillaume Gourcerol; Muriel Quillard; Alberto Zalar; Moïse Coëffier; Pierre Dechelotte; Anne-Marie Leroi; Philippe Ducrotté
Journal:  United European Gastroenterol J       Date:  2016-06-23       Impact factor: 4.623

7.  Nutrition: Searching for the immunological basis of wheat sensitivity.

Authors:  Antonio Carroccio
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-21       Impact factor: 46.802

8.  Confocal Laser Endomicroscopy in the Management of IBD: Clearly Superior?

Authors:  Alastair J M Watson
Journal:  Dig Dis Sci       Date:  2016-07       Impact factor: 3.199

9.  Presence of intraepithelial food antigen in patients with active eosinophilic oesophagitis.

Authors:  E V Marietta; D M Geno; T C Smyrk; A Becker; J A Alexander; M Camilleri; J A Murray; D A Katzka
Journal:  Aliment Pharmacol Ther       Date:  2016-11-22       Impact factor: 8.171

Review 10.  Position paper: The potential role of optical biopsy in the study and diagnosis of environmental enteric dysfunction.

Authors:  Alex J Thompson; Michael Hughes; Salzitsa Anastasova; Laurie S Conklin; Tudor Thomas; Cadman Leggett; William A Faubion; Thomas J Miller; Peter Delaney; François Lacombe; Sacha Loiseau; Alexander Meining; Rebecca Richards-Kortum; Guillermo J Tearney; Paul Kelly; Guang-Zhong Yang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-15       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.